• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过定点诱变确定人速激肽NK-2受体的肽类和非肽类NK-2受体拮抗剂结合位点的分子决定因素。

Molecular determinants of peptide and nonpeptide NK-2 receptor antagonists binding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis.

作者信息

Giolitti A, Cucchi P, Renzetti A R, Rotondaro L, Zappitelli S, Maggi C A

机构信息

Department of Drug Design, Menarini Ricerche, Via Sette Santi 3, Firenze, Italy.

出版信息

Neuropharmacology. 2000 Jun 8;39(8):1422-9. doi: 10.1016/s0028-3908(00)00008-3.

DOI:10.1016/s0028-3908(00)00008-3
PMID:10818258
Abstract

A series of 14 mutants on nine selected residues of the human tachykinin NK(2) receptor was produced and stably transfected into CHO cells to investigate the binding of the peptide MEN 11420 and the nonpeptide SR 48968 antagonists. The main interactions found for MEN 11420 were with Thr171, Tyr206, Tyr266 and Phe270. In the case of SR 48968 crucial residues were Tyr266 and Tyr289. While some overlapping of the binding sites exists, the binding modes suggested by this study appear not to allow structural correlation, and therefore general SAR, between these two antagonists.

摘要

在人速激肽NK(2)受体的九个选定残基上产生了一系列14个突变体,并将其稳定转染到CHO细胞中,以研究肽类MEN 11420和非肽类SR 48968拮抗剂的结合情况。发现MEN 11420的主要相互作用位点是苏氨酸171、酪氨酸206、酪氨酸266和苯丙氨酸270。对于SR 48968而言,关键残基是酪氨酸266和酪氨酸289。虽然存在一些结合位点的重叠,但本研究提出的结合模式似乎不允许这两种拮抗剂之间存在结构相关性,因此也不存在一般的构效关系。

相似文献

1
Molecular determinants of peptide and nonpeptide NK-2 receptor antagonists binding sites of the human tachykinin NK-2 receptor by site-directed mutagenesis.通过定点诱变确定人速激肽NK-2受体的肽类和非肽类NK-2受体拮抗剂结合位点的分子决定因素。
Neuropharmacology. 2000 Jun 8;39(8):1422-9. doi: 10.1016/s0028-3908(00)00008-3.
2
Relevance of aromatic residues in transmembrane segments V to VII for binding of peptide and nonpeptide antagonists to the human tachykinin NK(2) receptor.
J Pharmacol Exp Ther. 1999 Aug;290(2):487-95.
3
Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.对人速激肽NK(2)受体进行诱变以确定一类新型拮抗剂的结合位点。
Eur J Pharmacol. 2004 Mar 19;488(1-3):61-9. doi: 10.1016/j.ejphar.2004.02.016.
4
Pharmacological evaluation of alpha and beta human tachykinin NK(2) receptor splice variants expressed in CHO cells.
Eur J Pharmacol. 2004 Sep 24;499(3):229-38. doi: 10.1016/j.ejphar.2004.07.075.
5
Multifaceted approach to determine the antagonist molecular mechanism and interaction of ibodutant ([1-(2-phenyl-1R-[[1-(tetrahydropyran-4-ylmethyl)-piperidin-4-ylmethyl]-carbamoyl]-ethylcarbamoyl)-cyclopentyl]-amide) at the human tachykinin NK2 receptor.采用多方面方法确定依博杜坦([1-(2-苯基-1R-[[1-(四氢吡喃-4-基甲基)-哌啶-4-基甲基]-氨基甲酰基]-乙基氨基甲酰基)-环戊基]-酰胺)在人速激肽NK2受体上的拮抗分子机制及相互作用。
J Pharmacol Exp Ther. 2009 May;329(2):486-95. doi: 10.1124/jpet.108.150201. Epub 2009 Feb 13.
6
Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor.[3H]MEN 11420的特性研究,一种速激肽NK2受体的新型糖基化肽拮抗剂放射性配体。
Biochem Biophys Res Commun. 1998 Jul 9;248(1):78-82. doi: 10.1006/bbrc.1998.8883.
7
Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.一种新型选择性非肽类人速激肽NK2受体拮抗剂配体的药理学
Eur J Pharmacol. 2005 Jun 1;516(2):104-11. doi: 10.1016/j.ejphar.2005.04.033.
8
The species selectivity of chemically distinct tachykinin nonpeptide antagonists is dependent on common divergent residues of the rat and human neurokinin-1 receptors.化学结构不同的速激肽非肽拮抗剂的物种选择性取决于大鼠和人类神经激肽-1受体的共同差异残基。
Mol Pharmacol. 1994 Feb;45(2):294-9.
9
Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.新型速激肽拮抗剂YM-44781、YM-44778和YM-49598在药物诱导膀胱收缩模型中的作用
Pharmacology. 2002 May;65(2):96-102. doi: 10.1159/000056193.
10
The non-peptide tachykinin NK2 receptor antagonist SR 48968 interacts with human, but not rat, cloned tachykinin NK3 receptors.非肽速激肽NK2受体拮抗剂SR 48968可与人源而非大鼠源的克隆速激肽NK3受体相互作用。
Biochem Biophys Res Commun. 1994 Feb 15;198(3):967-72. doi: 10.1006/bbrc.1994.1138.

引用本文的文献

1
Pharmacophore and receptor models for neurokinin receptors.神经激肽受体的药效团和受体模型
J Comput Aided Mol Des. 2003 Nov;17(11):765-83. doi: 10.1023/b:jcam.0000017497.58165.d8.